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Introduction
T he skin is an attractive target for gene medicine, particularly for applications pertaining to cutaneous diseases, vaccines, and some metabolic disorders. It is easily accessible for both delivery and monitoring. As with any gene transfer approach, it is essential to develop a reliable delivery system. Electroporation is an effective means of delivering plasmid DNA to many tissues in vivo (Heller and Heller, 2006) . Several studies have shown that electroporation efficiently delivers plasmid DNA to the skin, increasing local and serum expression levels compared with injection alone (Titomirov et Electroporation of skin is a simple delivery method for prophylactic or therapeutic gene therapy applications. A key component of delivery is the electrode applicator used to apply the electric fields. Current electrode systems are cumbersome and typically induce significant muscle twitching and discomfort. This is related to the distance between the electrodes and the applied voltage. The current designs are also limited with respect to expandability, and the number of addressable electrode pairs that are contained within the electrode applicator is also limited, which impacts the directional control of the fields.
This brief report describes an approach that could overcome these limitations. A multielectrode array (MEA) applicator ( Fig. 1 ) was developed. With the MEA, the applied voltage is minimized by maintaining a short electrode distance. By reducing the distance between the electrodes, the area of tissue affected by each electric pulse and the depth of penetration of the field are reduced as well. This diminishes or eliminates the muscle twitching and sensation (discomfort) associated with the application of the pulsed electric fields. In addition, the electrodes within the applicator are independently addressable for directional control of the field.
Finally, the treatment area can eventually be expanded by the addition of rows of electrodes to the array. In this way, the treatment area can be increased without increasing the applied voltage.
Materials and Methods
Plasmid gWizLuc was commercially prepared (Aldevron, Fargo, ND). Endotoxin levels were <0.1 EU=mg plasmid.
Animals
Female Hartley guinea pigs (250-300 g) or male Sprague Dawley rats (200-250 g) were used in this study. All animals were anesthetized in an induction chamber charged with 3% isoflurane in O 2 and then fitted with a standard rodent mask and kept under general anesthesia during treatment.
Electroporation procedure
Animals received an intradermal injection of gWizLuc (2 mg=ml) in sterile injectable saline via the abdomen (rat) or 
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flank (guinea pig) followed immediately by administration of electric pulses. For those groups receiving electric pulses with the 4PE, the electrode was placed around the injection site and two sets of four pulses in perpendicular directions were administered as previously described (Heller et al., 2007 . The 4PE consists of four stainless steel plates (3.5 mm wide) that are insulated except for 2-3 mm at the bottom of each inside face. The four plates are situated around a nonconductive ''stopper'' that orients the plates to form a 6Â6 mm square. This allows the 4PE to be placed around a 6-mm-diameter area formed after the 50-ml injection. In addition, this orientation allows pulses to be applied in two electric field orientations at a 908 angle. For those groups receiving electric pulses with the MEA, the applicator was placed over the injection site and pulses were applied via groups of four electrodes. The firing sequence covered a series of 2Â2 mm squares and was fired as follows ( Fig. 1B ): 1 and 5 to 2 and 6; 1 and 2 to 5 and 6; 5 and 9 to 6 and 10; 5 and 6 to 9 and 10; 9 and 13 to 10 and 14; 9 and 10 to 13 and 14; 2 and 6 to 3 and 7; 2 and 3 to 6 and 7, and so on. The electric pulses were generated with a high-voltage power supply (HV Rack, 1=4C24-P250; Ultravolt, Ronkonkoma, NY). The applied voltage was controlled by the high-voltage power supply, whereas pulse width, pulse frequency, and pulsing sequence were controlled by a customized program using LabVIEW 8.2.1 (National Instruments, Austin, TX). The applied voltages were varied as described.
Luciferase reporter assay
At the indicated time points after plasmid delivery, luciferase activity was quantified as previously described (Heller et al., 2000) . Activity was expressed as total nanograms of luciferase per tissue sample. Statistical analysis was performed by Kruskal-Wallis nonparametric analysis of variance. Group differences were compared by Dunn's multiple comparisons test.
Histological analysis
Forty-eight hours after treatment, guinea pigs were killed and the 6-mm-diameter treated area was removed. Each sample was fixed and four sections were stained with hematoxylin and eosin and then examined histologically for damage. Samples were graded for percent damage, using a schema including surface damage (burning and=or necrosis) and subepidermal necrosis (Heller et al., 2007) . The total amount of damage (surface and subepidermal area affected) was determined as a percentage of the total treatment area.
Results and Discussion
Delivery of plasmid DNA to the skin by electroporation was previously evaluated in both mouse and rat skin, using a specially constructed electrode (4PE; see Materials and Methods) (Heller et al., 2007 . Skin delivery has been performed with caliper electrodes as well. Although cutaneous delivery was successful and high levels of expression were achieved, these electrode designs have some drawbacks. First, the field is developed across a small set of anodes and cathodes that are kept a specific distance apart. With the exception of relatively small surface areas, these designs prevent optimal interaction of the applicator with the target tissue. Second, the nature of these electrode designs produces excessive distance between the electrode pairs, which requires additional voltage to create the desired field strength. Thus, the administration of electric pulses results in significant muscle stimulation. This stimulation has been associated with pain or discomfort in clinical studies ( ). This becomes an important issue, particularly if it is necessary to treat a large area to obtain therapeutic levels of a delivered transgene. To reduce the sensation associated with the administration of electric pulses through the electrodes, another electrode configuration was developed and tested. The MEA (Fig. 1 ) contained 16 electrodes configured in 4 rows of 4 electrodes with a 2-mm electrode separation. The electrodes within the MEA are independently addressable and thus can be administered in specific pulsing patterns. Intradermal delivery of a plasmid encoding luciferase was used to evaluate the effectiveness of this new design in a Sprague Dawley rat model (Fig. 2) . Several electroporation parameters, based on previous results with the 4PE, were tested and the levels of expression compared with delivery with the 4PE (four pulses applied in two perpendicular directions for a total of eight pulses). The pulsing pattern of the MEA was similar to the 4PE, with separate pulses applied in perpendicular directions between each group of four electrodes. Four pulses were administered between each of the anode-cathode pairs (two perpendicular directions for a total of eight pulses) in a series of 2-mm squares as described in Materials and Methods. The MEA contains a total of nine 2-mm squares and therefore a complete MEA sequence included 72 pulses.
These results show that both electrode configurations can effectively deliver this reporter plasmid. All electroporation conditions tested with both electrodes showed significantly   FIG. 3 . Delivery of gWizLuc to Hartley guinea pig skin with MEA and 4PE. Intradermal injection of gWizLuc plasmid (50 ml, 2 mg=ml) was performed via the flank. (A) Electroporation was performed with the MEA or 4PE at the specified field strengths and pulse widths. Columns and error bars represent the mean of the means and standard error of the means for three replicate experiments. **p < 0.01, comparing the MEA with injection alone or 4PE. Pþ, injection with gWizLuc; EÀ, no electroporation; Eþ, electroporation administered. (B) Electroporation was performed with the MEA at the specified field strengths at a pulse width of 150 msec. Columns and error bars represent the mean of the means and standard error of the means. For 250 and 300 V=cm there were eight replicate experiments; for 200 V=cm there were four replicate experiments; and for 350 V=cm there were three replicate experiments of four samples each. *p < 0.05; **p < 0.01 when compared with injection alone (eight replicate experiments).
higher expression than injection of plasmid without electroporation. In addition, both the 4PE pulsing conditions and the 300 V=cm, 150 msec pulsing conditions with the MEA were significantly higher than the levels obtained with the MEA at 100 V=cm and 300 msec. These results suggest that the applied electric field strength is an important consideration, because comparable expression was obtained with increased field strength, but not with increased pulse duration. Although it was necessary to increase the field strength to achieve comparable expression patterns with the MEA, muscle stimulation during pulse administration was greatly reduced or eliminated with the MEA applicator when compared with the pronounced muscle contractions seen with the 4PE and caliper electrodes. Although this is not testable in animals, this suggests that the potential discomfort associated with delivery using this electrode design would be reduced or eliminated.
To better simulate delivery to skin similar in thickness to human skin, a second series of experiments to test the MEA was performed with guinea pigs. Expression in guinea pig skin, using parameters of 300 V=cm and 150 msec (Fig. 3A) , was higher than that observed in rat skin ( p < 0.01) when using the MEA and the same pulsing conditions. Interestingly, expression levels obtained with the 4PE and the same parameters as with rat skin were greatly reduced. Expression levels obtained with the MEA were significantly higher ( p < 0.01) than those obtained with the 4PE or injection only (Fig. 3A) . As was seen in the rat studies, there was a greatly reduced level of muscle twitching with the MEA compared with the 4PE. The effect of varying the field strength with the MEA was also evaluated. Delivery of plasmid with applied field strengths of 250, 300, and 350 V=cm at a pulse width of 150 msec resulted in significantly higher expression than injection of plasmid without electroporation (Fig. 3B) . Expression levels did not significantly differ between these three groups. Delivery of plasmid with an applied field strength of 200 V=cm at a pulse width of 150 msec did not result in significantly higher expression than injection of plasmid without electroporation.
In addition to expression levels, it was also critical to determine whether delivery with the MEA caused damage to the skin. The delivery was repeated using injection of plasmid alone, injection of plasmid with electroporation at 300 V=cm and 150 msec, or injection of saline without electroporation (four samples for each group). Guinea pigs were killed 48 hr after the procedure and the treated area was removed for histological evaluation. Minimal to no damage was seen in the guinea pigs receiving plasmid and saline injection. Less than 5% damage was seen in the electroporated samples. These results are similar to what was reported previously when delivery was performed to mouse skin (Heller et al., 2007) .
Electroporation is a powerful tool for use in nonviral gene therapy. Efficient and effective delivery has been accomplished preclinically to a variety of tissues and for multiple therapeutic applications (Heller and Heller, 2006 ; BodlesBrakhop et al., 2009). The first clinical trials using this delivery approach for gene therapy have been initiated. The results from the first trial have been reported and demonstrate the effectiveness of this approach in the delivery of the immune modulator interleukin-12 to melanomas (Daud et al., 2008) . The results presented here show that effective delivery of plasmid DNA can be accomplished with a multielectrode array. This array was designed to maintain the distance between electrodes independent of the actual delivery area, minimizing the applied voltage needed for delivery. Although a higher applied field at the same applied voltage was needed compared with a standard electrode, the muscle twitching associated with application of electric fields was observed to be drastically reduced. These improvements to the electrode applicator will facilitate the translation of electroporation-mediated gene delivery to the clinic for use with DNA vaccines or for therapies for cancer or protein deficiencies.
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